Acquired echinocandin resistance in a Candida krusei isolate due to modification of glucan synthase (Q34576400)

3 August 2017

title

Acquired echinocandin resistance in a Candida krusei isolate due to modification of glucan synthase (English)

1 reference

3 August 2017

1 reference

ChEBI release 2020-05-28

Candida krusei

1 reference

5

Kieren A Marr

1 reference

3 August 2017

author name string

Jennifer Nielsen Kahn

1

1 reference

3 August 2017

Guillermo Garcia-Effron

2

1 reference

3 August 2017

Ming-Jo Hsu

3

1 reference

3 August 2017

Steven Park

4

1 reference

3 August 2017

David S Perlin

6

1 reference

3 August 2017

language of work or name

English

0 references

publication date

26 February 2007

1 reference

Antimicrobial Agents and Chemotherapy

3 August 2017

number of pages

3

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

3 August 2017

volume

51

1 reference

3 August 2017

issue

5

1 reference

3 August 2017

page(s)

1876-1878

1 reference

Global surveillance of in vitro activity of micafungin against Candida: a comparison with caspofungin by CLSI-recommended methods.

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855530

Candida albicans and Candida glabrata clinical isolates exhibiting reduced echinocandin susceptibility

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855530

Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855530

Fluconazole for the management of invasive candidiasis: where do we stand after 15 years?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855530

In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855530

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855530

Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855530

Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855530

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855530

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855530

In vitro activities of caspofungin compared with those of fluconazole and itraconazole against 3,959 clinical isolates of Candida spp., including 157 fluconazole-resistant isolates.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855530

Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855530

Strain typing and determination of population structure of Candida krusei by multilocus sequence typing.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855530

Progressive esophagitis caused by Candida albicans with reduced susceptibility to caspofungin.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855530

Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855530

Antifungal activities of fluconazole, caspofungin (MK0991), and anidulafungin (LY 303366) alone and in combination against Candida spp. and Crytococcus neoformans via time-kill methods

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1855530

Auxotrophic heterozygosities and the ploidy of Candida parapsilosis and Candida krusei

27 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17325225

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00067-07

1 reference

3 August 2017

1 reference

3 August 2017

1 reference